As vasogenic changes secondary to hyperglycemia begins the cascade of macular edema formation causing a failure in the RPE pump function [14,27,28], we suppose SRD may be an indicator of earlier stage DME, which responds well to IVIR and seldom transforms into other subtypes under intravitreal anti-VEGF therapy. This evidence concerns the gene VEGFA and Hyperglycemia.